2-[4-[3-(2-amino-6-butylpyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]pyrazol-1-yl]-1-piperidin-1-ylethanone;4-(5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-6-butylpyrimidin-2-amine;1-piperidin-1-yl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethanone

C56H72BBrN16O4 — CID 158977904

IUPAC2-[4-[3-(2-amino-6-butylpyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]pyrazol-1-yl]-1-piperidin-1-ylethanone;4-(5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-6-butylpyrimidin-2-amine;1-piperidin-1-yl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethanone
SMILESCC1(C)OB(c2cnn(CC(=O)N3CCCCC3)c2)OC1(C)C.CCCCc1cc(-c2c[nH]c3ncc(-c4cnn(CC(=O)N5CCCCC5)c4)cc23)nc(N)n1.CCCCc1cc(-c2c[nH]c3ncc(Br)cc23)nc(N)n1
InChIInChI=1S/C25H30N8O.C16H26BN3O3.C15H16BrN5/c1-2-3-7-19-11-22(31-25(26)30-19)21-14-28-24-20(21)10-17(12-27-24)18-13-29-33(15-18)16-23(34)32-8-5-4-6-9-32;1-15(2)16(3,4)23-17(22-15)13-10-18-20(11-13)12-14(21)19-8-6-5-7-9-19;1-2-3-4-10-6-13(21-15(17)20-10)12-8-19-14-11(12)5-9(16)7-18-14/h10-15H,2-9,16H2,1H3,(H,27,28)(H2,26,30,31);10-11H,5-9,12H2,1-4H3;5-8H,2-4H2,1H3,(H,18,19)(H2,17,20,21)
InChIKeyJOPVEVKEDZSPDL-UHFFFAOYSA-N
MW1124.02 g/mol
LogP8.72
Rot. Bonds14

About 2-[4-[3-(2-amino-6-butylpyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]pyrazol-1-yl]-1-piperidin-1-ylethanone;4-(5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-6-butylpyrimidin-2-amine;1-piperidin-1-yl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethanone

2-[4-[3-(2-amino-6-butylpyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]pyrazol-1-yl]-1-piperidin-1-ylethanone;4-(5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-6-butylpyrimidin-2-amine;1-piperidin-1-yl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethanone (PubChem CID 158977904) has the molecular formula C56H72BBrN16O4 and a molecular weight of 1124.02 g/mol. Its IUPAC name is 2-[4-[3-(2-amino-6-butylpyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]pyrazol-1-yl]-1-piperidin-1-ylethanone;4-(5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-6-butylpyrimidin-2-amine;1-piperidin-1-yl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethanone.

Molecular Properties

Compound Name2-[4-[3-(2-amino-6-butylpyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]pyrazol-1-yl]-1-piperidin-1-ylethanone;4-(5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-6-butylpyrimidin-2-amine;1-piperidin-1-yl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethanone
PubChem CID158977904
Molecular FormulaC56H72BBrN16O4
Molecular Weight1124.02 g/mol
Exact Mass1122.52
IUPAC Name2-[4-[3-(2-amino-6-butylpyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]pyrazol-1-yl]-1-piperidin-1-ylethanone;4-(5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-6-butylpyrimidin-2-amine;1-piperidin-1-yl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethanone
SMILESCC1(C)OB(c2cnn(CC(=O)N3CCCCC3)c2)OC1(C)C.CCCCc1cc(-c2c[nH]c3ncc(-c4cnn(CC(=O)N5CCCCC5)c4)cc23)nc(N)n1.CCCCc1cc(-c2c[nH]c3ncc(Br)cc23)nc(N)n1
InChIInChI=1S/C25H30N8O.C16H26BN3O3.C15H16BrN5/c1-2-3-7-19-11-22(31-25(26)30-19)21-14-28-24-20(21)10-17(12-27-24)18-13-29-33(15-18)16-23(34)32-8-5-4-6-9-32;1-15(2)16(3,4)23-17(22-15)13-10-18-20(11-13)12-14(21)19-8-6-5-7-9-19;1-2-3-4-10-6-13(21-15(17)20-10)12-8-19-14-11(12)5-9(16)7-18-14/h10-15H,2-9,16H2,1H3,(H,27,28)(H2,26,30,31);10-11H,5-9,12H2,1-4H3;5-8H,2-4H2,1H3,(H,18,19)(H2,17,20,21)
InChIKeyJOPVEVKEDZSPDL-UHFFFAOYSA-N
XLogP8.72
TPSA255.68 Ų
H-Bond Donors4
H-Bond Acceptors16
Rotatable Bonds14
Heavy Atoms78
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001124.02
LogP ≤ 58.72
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 2-[4-[3-(2-amino-6-butylpyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]pyrazol-1-yl]-1-piperidin-1-ylethanone;4-(5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-6-butylpyrimidin-2-amine;1-piperidin-1-yl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethanone with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[4-[3-(2-amino-6-butylpyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]pyrazol-1-yl]-1-piperidin-1-ylethanone;4-(5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-6-butylpyrimidin-2-amine;1-piperidin-1-yl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethanone?
The IUPAC name of 2-[4-[3-(2-amino-6-butylpyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]pyrazol-1-yl]-1-piperidin-1-ylethanone;4-(5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-6-butylpyrimidin-2-amine;1-piperidin-1-yl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethanone (CID 158977904) is 2-[4-[3-(2-amino-6-butylpyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]pyrazol-1-yl]-1-piperidin-1-ylethanone;4-(5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-6-butylpyrimidin-2-amine;1-piperidin-1-yl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethanone.
What is the SMILES notation for 2-[4-[3-(2-amino-6-butylpyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]pyrazol-1-yl]-1-piperidin-1-ylethanone;4-(5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-6-butylpyrimidin-2-amine;1-piperidin-1-yl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethanone?
The canonical SMILES for 2-[4-[3-(2-amino-6-butylpyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]pyrazol-1-yl]-1-piperidin-1-ylethanone;4-(5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-6-butylpyrimidin-2-amine;1-piperidin-1-yl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethanone is CC1(C)OB(c2cnn(CC(=O)N3CCCCC3)c2)OC1(C)C.CCCCc1cc(-c2c[nH]c3ncc(-c4cnn(CC(=O)N5CCCCC5)c4)cc23)nc(N)n1.CCCCc1cc(-c2c[nH]c3ncc(Br)cc23)nc(N)n1.
What is the InChIKey of 2-[4-[3-(2-amino-6-butylpyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]pyrazol-1-yl]-1-piperidin-1-ylethanone;4-(5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-6-butylpyrimidin-2-amine;1-piperidin-1-yl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethanone?
The InChIKey is JOPVEVKEDZSPDL-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H30N8O.C16H26BN3O3.C15H16BrN5/c1-2-3-7-19-11-22(31-25(26)30-19)21-14-28-24-20(21)10-17(12-27-24)18-13-29-33(15-18)16-23(34)32-8-5-4-6-9-32;1-15(2)16(3,4)23-17(22-15)13-10-18-20(11-13)12-14(21)19-8-6-5-7-9-19;1-2-3-4-10-6-13(21-15(17)20-10)12-8-19-14-11(12)5-9(16)7-18-14/h10-15H,2-9,16H2,1H3,(H,27,28)(H2,26,30,31);10-11H,5-9,12H2,1-4H3;5-8H,2-4H2,1H3,(H,18,19)(H2,17,20,21).
What are the key properties of 2-[4-[3-(2-amino-6-butylpyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]pyrazol-1-yl]-1-piperidin-1-ylethanone;4-(5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-6-butylpyrimidin-2-amine;1-piperidin-1-yl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethanone?
2-[4-[3-(2-amino-6-butylpyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]pyrazol-1-yl]-1-piperidin-1-ylethanone;4-(5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-6-butylpyrimidin-2-amine;1-piperidin-1-yl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethanone has a molecular weight of 1124.02 g/mol, XLogP of 8.72, 14 rotatable bonds, 4 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[4-[3-(2-amino-6-butylpyrimidin-4-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]pyrazol-1-yl]-1-piperidin-1-ylethanone;4-(5-bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-6-butylpyrimidin-2-amine;1-piperidin-1-yl-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]ethanone is sourced from PubChem (CID 158977904), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).